Intelligent Patient-Controlled Liquid Oral Medicine Dispenser and Deactivation System

Publication ID: 24-11857504_0003_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Patient-Controlled Liquid Oral Medicine Dispenser and Deactivation System,” Published Technical Disclosure No. 24-11857504_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857504_0003_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,504.

Summary of the Inventive Concept

A synergistic system integrating a patient-controlled liquid oral medicine dispenser and deactivation system with AI, IoT, blockchain, and nanomaterial technologies to provide secure, personalized, and adaptive medication management.

Background and Problem Solved

The original patent addressed the limitations of invasive patient-controlled medication administration methods, including complexity, infection risks, and diversion potential. The new inventive concept builds upon this foundation by incorporating advanced technologies to overcome the remaining challenges, such as medication adherence, diversion prevention, and real-time monitoring.

Detailed Description of the Inventive Concept

The intelligent system comprises a patient-controlled liquid oral medicine dispenser and deactivation system integrated with an AI-powered medication management platform, IoT sensors, a blockchain-based ledger, and a nanomaterial-based sensor. The AI platform monitors and adapts to patient behavior to optimize medication dosing and prevent diversion. IoT sensors track medication usage patterns and transmit data to a remote server for analysis and feedback. The blockchain-based ledger records and verifies medication administration events, ensuring tamper-proof tracking. The nanomaterial-based sensor detects and responds to medication tampering or diversion attempts. The system can be implemented in various forms, including wearable devices and smart medication containers, to provide personalized medication recommendations and alerts.

Novelty and Inventive Step

The new claims introduce the novel combination of AI, IoT, blockchain, and nanomaterial technologies with the patient-controlled liquid oral medicine dispenser and deactivation system, providing a synergistic solution that addresses the limitations of the original patent. The inventive step lies in the integration of these distinct technologies to create a more powerful, secure, and adaptive medication management system.

Alternative Embodiments and Variations

Alternative embodiments may include integrating the system with electronic health records, using machine learning algorithms to predict patient behavior, or incorporating additional sensors to monitor medication efficacy. Variations may include using different AI platforms, IoT protocols, or blockchain architectures to achieve the same synergistic effect.

Potential Commercial Applications and Market

The intelligent patient-controlled liquid oral medicine dispenser and deactivation system has significant commercial potential in the healthcare industry, particularly in the areas of medication management, patient safety, and personalized medicine. Target markets may include hospitals, clinics, pharmacies, and healthcare technology companies.

CPC Classifications

Section	Class	Group
A	A61	A61J7/0053
A	A61	A61J1/22
G	G16	G16H20/13
A	A61	A61J2200/30
A	A61	A61J2200/70

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical Device Technology, Specifically Patient-Controlled Medication Delivery Systems with Focus on Oral Liquid Medicine Dispensing and Diversion Prevention

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in pharmaceutical delivery systems, IoT technologies, data analytics, and medication management protocols with advanced knowledge of patient safety and technology integration

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies like AI, IoT, and blockchain with existing medication dispensing systems represents a predictable technological evolution addressing known challenges in medication management. The source patent's core focus on preventing medication diversion naturally invites technological augmentation through monitoring and tracking solutions. The proposed variations represent incremental improvements using well-established technological approaches that would be obvious to implement given the existing technical framework.

Obvious Combinations & Variations

Source Patent Element

Dosing container with defined volumetric capacity and spillway to prevent excess medication delivery

PTD Variation

Adding IoT sensors to monitor and report precise medication usage patterns

Obviousness Reasoning

Extending medication tracking through digital sensors is a predictable solution for enhancing existing mechanical control mechanisms, representing a known technique in medical device monitoring

Source Patent Element

Sealed waste receptacle with neutralizing agent to prevent medication diversion

PTD Variation

Incorporating nanomaterial-based sensors to detect tampering attempts

Obviousness Reasoning

Enhancing anti-diversion mechanisms through advanced sensing technologies represents a logical progression in security design, utilizing finite identified solutions for improving existing protective systems

Source Patent Element

Patient-controlled liquid medicine dispenser with suction-based delivery mechanism

PTD Variation

Integrating AI platform to monitor and adapt medication dosing behavior

Obviousness Reasoning

Applying machine learning and behavioral analytics to medication delivery is a predictable technological extension for optimizing patient compliance and safety, representing a known approach in medical technology

Source Patent Element

Medication administration system with controlled dispensing

PTD Variation

Implementing blockchain-based ledger for verifying medication administration events

Obviousness Reasoning

Using distributed ledger technologies to create tamper-proof tracking represents an obvious technological solution for enhancing record-keeping and accountability in medical systems

35 U.S.C. § 103 Summary: Based on US Patent 11857504's teachings regarding patient-controlled liquid medicine dispensers, the present publication demonstrates that integrating digital monitoring, AI, blockchain, and advanced sensing technologies represents an obvious technological progression that would be readily conceived by a person having ordinary skill in medical device design, thereby rendering potential derivative claims obvious and non-patentable.

Original Patent Information

Patent Number	US 11,857,504
Title	Patient-controlled liquid oral medicine dispenser and deactivation system
Assignee(s)	Yale University